highly-ordered and hierarchical porosity scaffolds for ...s stokols, j sakamoto, c breckon, t holt,...
TRANSCRIPT
![Page 1: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/1.jpg)
Highly-ordered and hierarchical porosity scaffolds for nerve repair
J. SAKAMOTO1 (PH. D.) , D. LYNAM1 (PH. D.), D. SHAHRIARI1, K. KOFFLER2 (PH. D.), P. WALTON (SC. D.) C. CHAN1 (PH. D.),
AND M.H. TUSZYNSKI2,3 (M.D./PH.D.)
1MICHIGAN STATE UNIVERSITY, EAST LANSING, MI 2UNIV. OF CALIFORNIA-SAN DIEGO, LA JOLLA, CA
3DIRECTOR OF NEURAL REPAIR
NIBIB: 1R01EB014986-01 Bioengineered Scaffolds for Spinal Cord Injury
![Page 2: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/2.jpg)
2 2
Outline
•Introduction
•Nerve guidance scaffold design and fabrication
•Acellular drug delivery
![Page 3: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/3.jpg)
3
Initial trauma/nerve severance
Peripheral nerve regeneration
Metabolic function: changes from neuro transmittance to wound repair. Wallerian degeneration after 2-4 days clears fragments.
Remaining Schwann cells provide environment to promote axon extension.
Steve K Lee and ScottWWolfe. Peripheral nerve injury and repair. Journal of the American Academy of Orthopaedic Surgeons, 8(4):243–252, 2000.
![Page 4: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/4.jpg)
4
1.9% OF THE U.S. SUFFERS FROM SOME FORM OF PARALYSIS1
4
Condroitin sulfate proteoglycans and myelin-associated inhibitors cause irreversible scarring.
![Page 5: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/5.jpg)
5 Terry W Hudson, Gregory RD Evans, and Christine E Schmidt. Engineering strategies for peripheral nerve repair. Clinics in plastic surgery, 26(4), 1999.
State-of-the-art scaffold approaches
![Page 6: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/6.jpg)
6
Inverted Umbilical Artery Crouzier et al. J Biomed Mater Res 2009;89A:818-28
Braided polylactic co-glyc. acid Tube Bini et al. J Biomed Mater Res 2004;68A:286-95
Silicone Tube Lundborg et al. Exp Neur 1982;76:361-75
Punched Collagen Tube Moellers et al. Tissue Eng Pt A 2009;15:461-72
State-of-the-art scaffold examples
![Page 7: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/7.jpg)
7 S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787
•Continuous linear channels to provide physical guidance, “bridge-the-gap”
•Uniform wall thickness to enable high channel volume/scaffold volume
•Scaffold material: soft for biocompatibility, stiff enough to guide, and eventually degrade
•Timed and sustained delivery of drugs
Our approach: precision, micro-channel scaffolds
![Page 8: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/8.jpg)
8 8
Clinically-relevant scaffold fabrication technology
Requirements: 1. Discrete linear channels 1-2cm in length
2. 100-200mm diameter channels
3. Highly-ordered or uniform wall thickness
4. High channel/lumen volume: 40-80%
5. Compatible with biomaterials
6. Several cm2 of area
7. Precision superficial geometry (match to MRI scan)
8. Degradable
9. Capable of providing drug delivery
![Page 9: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/9.jpg)
9 9
J. Friedman et al., Neurosurgery, 51, 3 (2002) 742-752. (Mayo Clinic, Minnesota)
State-of-the art patterning technology
3D printing
Chen et al. Biomed Microdevices (2011) 13:983–993
Digital micro-mirror-array device (DMD)
![Page 10: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/10.jpg)
10
Gilbert et al. Acta Biomaterialia 6 (2010) 2970–2978
L. Flynn, P. Dalton and M. Shoichet, Biomaterials, 24 (2003) 4265-4272. (Univ. Toronto)
Shea et al. Biomaterials (2013).
PLGA: sugar fiber template
pHEMA: PCL fiber template Electrospun PLLA fibers
Fiber templating & electrospun scaffolds
![Page 11: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/11.jpg)
11
Macro-scale self-assembled templates
PMMA cladding
PS core
Paradigm Optics Inc.
Lateral dimensions range from: 100nm up to 1mm
![Page 12: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/12.jpg)
Non-polar Solvent Molten Agarose Polar Solvent
12
![Page 13: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/13.jpg)
Microchannel Volume Analysis
• Varying template W/MC ratio allows an areal fraction of open microchannels ranging from 0.4-0.79
Solid Line
Dashed Line
![Page 14: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/14.jpg)
14
1cm
200um
Scale-up
![Page 15: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/15.jpg)
15 15 15
Clinically-relevant scaffold fabrication technology
Requirements: 1. Discrete linear channels 1-2cm in length
2. 100-200mm diameter channels
3. Highly-ordered or uniform wall thickness
4. High channel/lumen volume: 40-80%
5. Compatible with biomaterials
6. Several cm2 of area
7. Precision superficial geometry (match to MRI scan)
8. Degradable
9. Capable of providing drug delivery
? ?
?
![Page 16: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/16.jpg)
In vivo cellular drug delivery
S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787
Previous work: Bone marrow stromal cells (BMSC) transfected to
secrete brain derived neurotrophic factor (BDNF)
C4 Dorsal
column model
16
Scalebar = 100 mm
![Page 17: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/17.jpg)
Acellular Drug Delivery
• Alternating layers of hydrogen-bonded polymers to deliver drugs or proteins – Layer-by-Layer – Hydrogen bond donor and hydrogen bond acceptor polymers with
protein in-between – In acidic environment, polymer layers assemble. At neutral pH,
polymers slowly disassemble – Can augment release by increasing surface area
Assembly in acidic environment Disassembly in neutral pH environment 17
100nm
![Page 18: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/18.jpg)
Layer-by-Layer Assembly
100nm
Hydrogel Network
18
S Mehrotra, D Lynam, R Maloney, KM Pawelec, MH Tuszynski, I Lee, C Chan, JS Sakamoto. Adv Func Mater. 2009;20:247–258
![Page 19: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/19.jpg)
Lysozyme Release
5wt%ag/50wt%sucrose
100nm
5wt%a/65wt%sucrose
100nm
0.01
0.1
1
10
0 1 2 3 4 5 6 7 8 9 10
Lyso
zym
e R
ele
ase
Pe
r D
ay
(µ
g/m
L) -
Lo
g Sc
ale
Day
Optimal BDNF release concentration
50ng/mL
Daily protein release from layer-by-layer
19
![Page 20: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/20.jpg)
20
Brain derived neurotrophic factor (BDNF) Release
![Page 21: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/21.jpg)
21
Proliferation AssayNIH 3T3 Fibroblasts
5 Days
Characterizing BDNF bioactivity after release
![Page 22: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/22.jpg)
22
E14 Stem cell graft
25 mm 25 mm
200um
Cell
![Page 23: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/23.jpg)
23 23
Summary
Developing scaffold patterning technology High aspect ratio channels, with clinically relevant dimensions
Compatible with hydrogels (agarose and alginate) Demonstrated high channel volume (80%) ? Fabricate biodegradable scaffolds (lasting months)
Developing and integrated drug delivery technology Layer-by-layer technology provides timed and relevant dose response
Combined Layer-by-layer with hydrogels to augment release ? Demonstrate clinically-relevant, bioactive BDNF release
On-going/future work
• Myelination-recruiting support cells • Peripheral nerve repair (closer to clinical relevance)
![Page 24: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/24.jpg)
24
Acknowledgements
NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING: 1R01EB014986-01 Bioengineered Scaffolds for Spinal Cord Injury
Dr. Daniel Lynam Dena Shahriari National Science Foundation Graduate Fellowship
K. Koffler (Ph. D.), M.H. Tuszynski (M.D./Ph.D)
Professor Kris Chan Professor Pat Walton
![Page 25: Highly-ordered and hierarchical porosity scaffolds for ...S Stokols, J Sakamoto, C Breckon, T Holt, J Weiss, and MH Tuszynski. Tissue Eng. 2006;12:2777-2787 7 •Continuous linear](https://reader031.vdocument.in/reader031/viewer/2022041720/5e4e36633e741120285c2c38/html5/thumbnails/25.jpg)
25
Brain Derived Neurotrophic Factor Incorporation into LbL
• Hydrochloric acid effects on BDNF, pH 2
S-S
S-S S-S
H+
H+
H+
Cl-
Cl-
Cl-
SH
SH
SH
Folded, active protein Denatured, inactive protein
❌ Does layer-by-layer assembly maintain BDNF activity?
How to stabilize BDNF for LbL? 1. More neutral assembly pH 2. Acetic acid incorporation 3. 4°C Assembly 4. Incorporation of carrier protein BSA 25